Darrell R. Abernethy

home / authors / darrell-r-abernethy

Darrell R. Abernethy, MD, PhD, is chief science officer, all at the United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, MD 20852-1790, tel. 301.816.8184, dra@usp.org

Articles

Site Logo

Inside USP: USP Metals Testing: A Workshop Report

Stefan Schuber;Anthony J. DeStefano, PhD;Roger L. Williams;William F. Koch;Darrell R. Abernethy
November 2nd 2008

Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.

Site Logo

Inside USP: Metrology and USP Dissolution

Thomas Foster;Darrell R. Abernethy;William F. Koch;Walter W. Hauck
March 2nd 2008

The United States Pharmacopeia emphasizes mechanical calibration and a performance test to esnure integrity of the dissolution procedure.

Latest Updated Articles

Buy, Sell, Hold: Cell and Gene Therapy
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: August 21st 2024 | Updated: December 30th 2024
Pharmaceutical Technology Editorial Advisory Board
Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics
Published: November 25th 2024 | Updated: December 30th 2024
Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Published: December 20th 2024 | Updated: December 30th 2024
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Europa Perspectives: Helping to Navigate the Regulatory System
Published: February 23rd 2024 | Updated: December 30th 2024
Europa Perspectives: Helping to Navigate the Regulatory System